NCT00480181: Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis |
|
|
| Completed | 4 | 50 | Canada | nabilone, Cesamet, placebo | University of Manitoba, Bausch Health Americas, Inc. | Neuropathic Pain, Multiple Sclerosis | 07/12 | 07/12 | | |
